Argus Investors' Counsel, Inc. Pfizer Inc Transaction History
Argus Investors' Counsel, Inc.
- $148 Million
- Q3 2024
A detailed history of Argus Investors' Counsel, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Argus Investors' Counsel, Inc. holds 27,940 shares of PFE stock, worth $716,661. This represents 0.55% of its overall portfolio holdings.
Number of Shares
27,940
Previous 39,240
28.8%
Holding current value
$716,661
Previous $1.1 Million
26.34%
% of portfolio
0.55%
Previous 0.68%
Shares
29 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.2 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.9 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.45 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.2 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.34 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $144B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...